MLEC
MOOLEC SCIENCE (MLEC)
NASDAQ
$8.22+$1.38 (+20.28%)
Price as of Jun 03, 2026 6:17 PM EDT
  • $2.5M
    Market Cap
  • -94.61%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2025
06/30/2024
06/30/2023
Income Statement
Total Operating Revenue
333.6M
+5,830.74%
5.6M
+521.53%
905,049
N/A
Cost of Revenue
203.4M
+3,848.05%
5.2M
+391.49%
1.0M
N/A
Gross Profit
784,364
+65.97%
472,581
+429.77%
-143,305
N/A
Sales and Marketing Expense
125.9M
+19,479.55%
643,060
+150.78%
256,421
N/A
Research and Development Expense
-15.1M
+754.19%
-1.8M
+31.16%
-1.4M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
122,022
N/A
Total Operating Expenses
125.9M
+50,686.65%
247,916
+128.95%
108,282
N/A
Operating Profit
-104.2M
+1,051.74%
-9.0M
+35.90%
-6.7M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-38.1M
+92,511.03%
-41,116
N/A
N/A
N/A
Interest Income and Expense and Net
-38.1M
+92,511.03%
-41,116
N/A
0
N/A
Total Nonoperating Income and Expense
38.1M
+7,585.25%
495,468
N/A
N/A
N/A
Income before Taxes
-176.6M
+2,315.66%
-7.3M
-85.88%
-51.8M
N/A
Income Taxes
6.6M
+733.83%
-1.0M
+346.40%
-234,542
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-176.6M
+2,315.66%
-7.3M
-85.88%
-51.8M
N/A
Net Income from Continuing Operations Applicable to Common
-176.6M
+2,315.66%
-7.3M
-85.88%
-51.8M
N/A
Basic EPS and Net Income
-17.25
+8,976.89%
-0.19
-87.33%
-1.50
N/A
Diluted EPS and Net Income
-17.25
+8,976.89%
-0.19
-87.33%
-1.50
N/A
Basic Weighted Average Shares
6.5M
N/A
N/A
N/A
N/A
N/A
Diluted Weighted Average Shares
6.5M
N/A
N/A
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
767,919
-85.75%
5.4M
+113.24%
2.5M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
767,919
-85.75%
5.4M
+113.24%
2.5M
N/A
Total Current Assets
31.2M
+126.88%
13.7M
+157.86%
5.3M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
3.3M
+60,500.91%
5,520
-99.52%
1.1M
N/A
Total Long-Term Assets
173.5M
+724.76%
21.0M
+12.39%
18.7M
N/A
Total Assets
204.7M
+488.47%
34.8M
+44.64%
24.1M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
227.2M
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
236.1M
+2,796.24%
8.2M
-35.31%
12.6M
N/A
Total Long-Term Debt
1.3M
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
51.5M
+159.98%
19.8M
+1,372.39%
1.3M
N/A
Total Liabilities
287.6M
+928.14%
28.0M
+100.58%
13.9M
N/A
Retained Earnings
-110.3M
+67.31%
-65.9M
+12.47%
-58.6M
N/A
Total Stockholders Equity
-82.9M
-1,315.91%
6.8M
-32.56%
10.1M
N/A
Total Shares Outstanding
N/A
N/A
N/A
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
3.6M
+138.98%
-9.3M
+24.19%
-7.5M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-36.0M
-26,784.17%
134,865
+105.77%
-2.3M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-15.0M
-228.26%
11.7M
+3.81%
11.3M
N/A
Financials Ratio
Gross Margin
39.02%
+364.49%
8.40%
N/A
N/A
N/A
Operating Margin
-31.22%
-80.58%
-160.76%
N/A
N/A
N/A
Return on Assets
-147.51%
+493.47%
-24.86%
N/A
N/A
N/A
Return on Equity
464.49%
+637.45%
-86.42%
N/A
N/A
N/A
Revenue Growth
5,830.74%
+1,018.01%
521.53%
N/A
N/A
N/A
Current Ratio
0.13
-92.17%
1.69
N/A
N/A
N/A
Cash Ratio
0.003
-99.50%
0.66
N/A
N/A
N/A
Debt-to-Equity Ratio
-2.76
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
1.12
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow